BGMD News Alert Bg Medicine (BGMD) 0.88 02/14/2015 20:16:04

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 9:16 PM

Bg Medicine (BGMD) 0.88 $BGMD

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 8:12AM CST

BGMD: 0.88 (unch), SD: 2.09 (+0.14), FRO: 2.96 (+0.07), CAMT: 3.08 (+0.09), PWE: 2.45 (+0.02), HIHO: 3.30 (-0.17), PSTI: 2.91 (+0.01), ZGNX: 1.43 (+0.05), NBG: 1.61 (+0.18), SDRL: 12.32 (-0.70), GURE: 1.64 (-0.04)

BG Medicine Announces Receipt of Favorable NASDAQ Listing Determination
GlobeNewswire - Mon Feb 02, 6:00AM CST
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3Test, announced today its receipt of a favorable decision from the Listing Qualifications Department (the "Staff"

of The NASDAQ Stock Market LLC ("NASDAQ"

, which granted the Company's request for continued listing on NASDAQ, pursuant to an extension within which to evidence compliance with NASDAQ Listing Rule 5550(b) (the "Rule"

. In the Company's case, the Rule requires the Company to evidence either a minimum of $2.5 million in stockholders' equity or a market capitalization of at least $35 million. The Company is diligently working to evidence compliance with the Rule on or before May 19, 2015, as required by the Staff.
BGMD: 0.88 (unch)

PAREXEL International Q2 Earnings, Revenues Top Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 10:40AM CST
PAREXEL International Corp's (PRXL) second-quarter fiscal 2015 adjusted earnings of 69 cents per share surged nearly 35.3% year over year on expanding margins.
BGMD: 0.88 (unch), PRXL: 62.91 (-0.18), ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)

BG Med surges again
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 2:25PM CST

BGMD: 0.88 (unch)

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
BOFI: 91.39 (-0.92), BGMD: 0.88 (unch), AUO: 5.45 (-0.14), AAC: 29.11 (+0.91), AAPL: 127.08 (+0.62)

Advisory Board Adds Royall to its Higher Education Lineup - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 2:20PM CST
The Advisory Board Company (ABCO) has announced the completion of its Royall & Company takeover.
BGMD: 0.88 (unch), ABCO: 53.69 (+0.32), AHS: 20.56 (-0.34), CGIX: 7.07 (unch)

BioTelemetry Raised to Strong Buy on Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 9:00AM CST
On Jan 6, 2014, Zacks Investment Research upgraded BioTelemetry, Inc. (BEAT) to a Zacks Rank #1 (Strong Buy)
BGMD: 0.88 (unch), CTRX: 53.24 (+0.65), ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)

Nasdaq stocks posting largest volume increases
AP - Tue Dec 30, 5:31PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
LARK: 22.50 (+0.15), NEON: 2.98 (+0.16), ADXS: 7.18 (+0.06), QLTI: 4.15 (unch), QLT.TO: 5.10 (-0.03), BRID: 7.55 (-0.04), XGTI: 0.43 (+0.01), WVFC: 11.02 (-0.45), BGMD: 0.88 (unch), SEED: 1.38 (-0.02), UPI: 1.27 (unch), JST: 5.35 (+0.14), GCBC: 29.50 (unch), KFFB: 8.02 (-0.13), CJJD: 2.59 (-0.01), MGYR: 8.45 (+0.04)

BG Medicine up big on approval of automated test
Seeking Alpha - at Seeking Alpha - Tue Dec 30, 3:09PM CST

BGMD: 0.88 (unch), ABT: 46.09 (+0.87)

BG Medicine, Inc. Welcomes Presentation of Clinical Data on Galectin-3 Testing at the American Heart Association 2014 Scientific Sessions Conference
GlobeNewswire - Thu Nov 20, 9:12AM CST
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test, announced today that 17 abstracts reporting independent research that investigates galectin-3 testing in various cardiovascular diseases have been presented at the American Heart Association's 2014 Scientific Sessions and Resuscitation Science Symposium, which was held in Chicago, Illinois during November 15-19, 2014.
BGMD: 0.88 (unch)

BG Medicine's (BGMD) CEO Paul Sohmer on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 9:43AM CST

BGMD: 0.88 (unch)

BG Med net loss improves in Q3
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:14AM CST

BGMD: 0.88 (unch)

BG Medicine (BGMD) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 13, 7:25AM CST

BGMD: 0.88 (unch)

BG Medicine EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 5:34AM CST

BGMD: 0.88 (unch)

BG Medicine Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 13, 5:30AM CST
Net Loss Reduced by 35% and Operating Cash Burn Cut by 48% From Third Quarter 2013
BGMD: 0.88 (unch)

Air Methods (AIRM) Crumbles: Stock Falls by 7.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:39AM CST
Shares of Air Methods (AIRM) fell by nearly 8% on the day. This continues the recent trend for AIRM, as the stock is now down over 23% since Oct 10. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue.
BGMD: 0.88 (unch), AIRM: 45.33 (+0.24), BEAT: 10.36 (+0.20), ICLR: 60.01 (+0.38)

BG Med reports November 13
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 10:09AM CST

BGMD: 0.88 (unch)

MedAssets Beats on Q3 Earnings, Revenues; Both Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:55AM CST
MedAssets, Inc. (MDAS) reported adjusted earnings per share (EPS) of 29 cents in the third quarter of 2014, beating the Zacks Consensus Estimate by couple of cents.
BGMD: 0.88 (unch), BEAT: 10.36 (+0.20), MDAS: 19.81 (+0.18), ICLR: 60.01 (+0.38)

PAREXEL International Beats Q1 Earnings, Misses Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:48AM CST
PAREXEL International (PRXL) reported adjusted earnings per share of 65 cents in the first quarter of fiscal 2015, which beat both the Zacks Consensus Estimate of 58 cents and the year-ago earnings of 45 cents.
BGMD: 0.88 (unch), PRXL: 62.91 (-0.18), BEAT: 10.36 (+0.20), ICLR: 60.01 (+0.38)

BG Medicine Announces Q3 2014 Financial Results Release Date and Conference Call Information
GlobeNewswire - Fri Nov 07, 9:45AM CST
BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, November 13, 2014 at 8:30 a.m. Eastern Time to discuss its Q3 2014 financial results before the market opens.
BGMD: 0.88 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celebree Gains Franchise Momentum: A New Frontier

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Montessori and Tech: A New Era of Integration

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Coventry's Jacobs Joins European Life Settlement Execs

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Skiptown Expands in Georgia Amid Growing Demand

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Veterans Transitioning to Real Estate with Scholarships

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

VetsinTech's AI Training Boosts Military Careers

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

CMC Declares Dividend Amid Complex Outlook

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Think Tank Pushes for Bold Parkinson's Prevention Plan

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...